Clinical trials
Intellectual Disability trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 5 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Hôpital le Vinatier | 3 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| University Hospital, Bordeaux | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| Groupe Hospitalier de la Region de Mulhouse et Sud Alsace | 1 |
| Institut Jerome Lejeune | 1 |
| METAFORA biosystems | 1 |
| University Hospital, Brest | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intellectual Disability | 17 |
| Autism Spectrum Disorder | 2 |
| Autistic Disorder | 2 |
| Disease | 2 |
| Rare Diseases | 2 |
| Abortion, Spontaneous | 1 |
| Albinism | 1 |
| Ataxia | 1 |
| Chromosome Aberrations | 1 |
| Congenital Abnormalities | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.